Antisense strategies to inhibit restenosis

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 5, 1999, Pages 487-492

  Millie, Lee ^a   Simon, Alan D ^a   Stein, C A ^a   Rabbani, Leroy E ^a  

^a Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; CHEMOATTRACTANT; CYCLINE; CYTIDINE; MITOGENIC AGENT; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL X; PROTEIN KINASE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; ZK 10;

ADVENTITIA; ARTERY WALL; BALLOON CATHETER; CAROTID ARTERY; CELL CYCLE; CELL PROLIFERATION; CORONARY ARTERY; CORONARY STENT; CPG ISLAND; INTIMA; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SURGICAL INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

SUIDAE;

EID: 0032723328     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1999.9.487     Document Type: Review

References (13)

1. ABE, J., ZHOU, W., TAGUCHI, J., TAKUWA, N., MIKI, K., OKAZAKI, H., KUROKAWA, K., KUMADA, M., and TAKUWA, Y. (1994). Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc 2 and cdk 2 oligonucleotides in rat carotid artery. Biochem. Biophys. Res. Commun. 198, 16-24.
2. BENNETT, M.R., and SCHWARTZ, S.M. (1995). Antisense therapy for angioplasty restenosis: Some critical considerations. Circulation 92, 1981-1993.
3. BENNETT, M.R., ANGELIN, S., MCEWAN, J.R., JAGOE, R., NEWBY, A.C., and EVAN, G.I. (1994). Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligonucleotides. J. Clin. Invest. 93, 820-828.
4. BENNETT, M.R., LINDNER, V., DEBLOIS, D., REIDY, M.A., and SCHWARTZ, S.M. (1997). Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery: Dissecting the mechanism of action. Arterioscler. Thromb. Vasc. Biol. 17, 2326-2332.
5. BIRO, S., FU, Y.M., YU, Z.X., and EPSTEIN, S.E. (1993). Inhibitory effects of antisense oligonucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA 90, 654-658.
6. BROWN, K.E., KINDY, M.S., and SONENSHEIN, G.E. (1992). Expression of the c-myc protooncogene in bovine vascular smooth muscle cells. J. Biol. Chem. 267, 4625-4630.
7. BURGESS, T.L., FISHER, E.F., ROSS, S.L., BREADY, J.V., QIAN, Y.-X., BAYEWITCH, L.A., COHEN, A.M., HERRERA, C.J., HU, S.S.-F., KRAMER, T.B., et al. (1995). The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92, 4051-4055.
8. DRACHMAN, D.E., EDELMAN, E.R., and ROGERS, C. (1999). Local delivery of antirestenotic drugs. In: Applications of Antisense Therapies to Restenosis, L.E. Rabbani, ed. (Kluwer Academic Publishers, Boston), pp. 153-161.
9. EBBECKE, M., UNTERBERG, C., BUCHWALD, A., STOHR, S., and WIEGAND, V. (1992). Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells. Basic. Res. Cardiol. 87, 585-591.
10. FISCHMAN, D.L., LEON, M.B., BAIM, D.S., et al. (1994). A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl. J. Med. 331, 496-501.
11. GAO, W.-Y., STORM, C., EGAN, W., and CHENG, Y.-C. (1992) Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol. Pharmacol. 43, 45-50.
12. WANG, W., CHEN, H.-J., WARSHOFSKY, M., SCHWARTZ, A., STEIN, C.A., and RABBANI, L.E. (1997b). Effects of S-dC28 on vascular smooth muscle cell adhesion and plasminogen activator production. Antisense Nucleic Acid Drug Dev. 7, 101-107.
13. WANG, W., CHEN, H.-J., SUN, J., BENIMETSKAYA, L., SCHWARTZ, A., CANNON, P., STEIN, C.A., and RABBANI, L.E. (1998). A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation. Antisense Nucleic Acid Drug Dev. 8, 227-236.